All authors Continuant Continuant Entity Entity Agent Independent Continuant Institute research investigator 2025-05-07T16:35:27 RDF description of Frey II, William H., PhD - http://repository.healthpartners.com/individual/person-Frey-W-H-2nd public person-Frey-W-H-Jr ¿ªÔÆÌåÓý Neuroscience Center Frey II, William H., PhD 2024-06-18T16:36:52 person-Frey-W-H <p>Overview/research interests: Intranasal delivery of therapeutics to treat and prevent brain damage from Alzheimer’s disease, Parkinson’s disease, stroke, traumatic brain injury, posttraumatic stress disorder, brain tumors and other brain disorders.</p> <ul> <li>Developed noninvasive, intranasal method for bypassing the blood-brain barrier to target central nervous system therapeutic agents to the brain and spinal cord while reducing system exposure and unwanted side effects</li> <li>Developed and patented intranasal insulin and showed that intranasal insulin improves memory in patients with Alzheimer’s disease</li> <li>Developed and patented method using intranasal insulin to treat and protect against traumatic brain injury</li> <li>Developed method using intranasal insulin to treat and protect against posttraumatic stress disorder</li> <li>Developed and patented intranasal deferoxamine for the treatment of Alzheimer’s disease, stroke, Parkinson’s disease, traumatic brain injury and other central nervous system disorders</li> <li>Developed and patented intranasal stem cells to bypass the blood-brain barrier and treat Parkinson’s disease, stroke, Alzheimer’s disease and other central nervous system disorders</li> <li>Leading expert in why humans uniquely evolved the ability to shed emotional tears in response to stress and the chemistry of emotional tears</li> <li>Research has been subject of articles in the <em>New York Times, Wall Street Journal, U.S. News and World Report </em>and numerous other newspapers and magazines</li> <li>Interviewed on the Today Show, Good Morning America, 20/20, All Things Considered, the BBC and numerous other TV and radio programs around the world</li> </ul> <p>Current research activities and funding: Intranasal delivery of therapeutics to treat and prevent brain damage from Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, stroke, traumatic brain injury, posttraumatic stress syndrome and other central nervous system disorders.</p> Sr. Director person-Frey-W-H-2nd Minnesota Hanson, Leah R., PhD